Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focetria in Immunocompromised Adults
NCT01069601Phase 2Terminated
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in H1N1 influenza (H1N1). Started Feb 2010; status: terminated.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT01069601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01069601.